Analysis of the Factors Causing Bladder Irritation after Transurethral Resection of the Prostate

다국어 초록 (Multilingual Abstract)

Purpose: Approximately 20% to 30% of patients with benign prostatic hyperplasia (BPH) require medication or supplementary treatment for their continuous irritative bladder symptoms after transurethral resection of the prostate (TURP). The purpose of this study was to identify any factors related to continuous bladder irritation in patients after TURP.
Materials and Methods: Of all patients who underwent TURP from January 2000 to December 2007, 160 who underwent long-term follow-up were selected for this study. The International Prostate Symptom Score (IPSS) was assessed 12 months after TURP, and the patients were divided into two groups: one group with an irritative bladder symptom score on the IPSS of 7 or less (non-irritative group) and another group with an irritative bladder symptom score on the IPSS of 8 or greater (irritative group). Preoperative urodynamic study variables, preoperative and postoperative IPSS, and the shape of the prostate upon transrectal ultrasonography (TRUS) were analyzed.
Results: Of the 160 patients, 93 patients were assigned to the non-irritative group, and 67 were assigned to the irritative group. Initial irritative bladder symptoms were significantly different between the two groups (p＜0.05). Also, a retrourethral enlarged prostate was more frequently observed upon TRUS in the irritative group. Symptoms of urinary frequency, incontinence, and urgency were significantly greater in the irritative group. Although there was no significant difference in the preoperative quality of life between the two groups, postoperative quality of life was significantly worse in the irritative group.
Conclusions: The shape of the prostate and the preoperative irritation score correlated significantly with the postoperative severity of irritative bladder symptoms. Therefore, physicians should be cautious when performing TURP in patients with a retrourethral enlarged prostate and severe irritative symptoms.

참고문헌 (Reference)

1 한경석, "최근 5년간 관찰한 전립선비대증 환자의 치료 경향의 변화" 대한비뇨기과학회 46 (46): 458-462, 2005

2 정호영, "경요도전립선절제술을 시행받은 환자에서 방광출구폐색이 저장증상 호전에 미치는 영향" 대한비뇨기과학회 49 (49): 912-916, 2008

3 남재근, "경요도전립선절제술 후 지속되는 하부요로증상 환자의 평가" 대한비뇨기과학회 44 (44): 540-544, 2003

4 Lee HS, "The outcome of TURP on lower urinary tract symptoms according to shape of prostate" 49 (49): 66-, 2008

5 Kim HH, "The effects and complications of transurethral resection for benign prostatic hyperplasia: results of long-term follow-up" 37 : 268-280, 1996

6 Kojima M, "Reversible change of bladder hypertrophy due to benign prostatic hyperplasia after surgical relief of obstruction" 158 : 89-93, 1997

7 Cote RJ, "Prediction of unusual postoperative results by urodynamic testing in benign prostatic hyperplasia" 125 : 690-692, 1981

8 Housami F, "Persistent detrusor overactivity after transurethral resection of the prostate" 9 : 284-290, 2008

9 Doll HA, "Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy" 147 : 1566-1573, 1992

10 Uchida T, "Factors influencing morbidity in patients undergoing transurethral resection of the prostate" 53 : 98-105, 1999

11 Rasweiler J, "Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention" 50 : 969-979, 2006

12 Dinis P, "Bladder C-fiber desensitization induces a long-lasting improvement of BPH-associated storage LUTS: a pilot study" 46 : 88-93, 2004

13 Wasserman NF, "Benign prostatic hyperplasia: a review and ultrasound classification" 44 : 689-710, 2006

14 Thorpe A, "Benign prostatic hyperplasia" 361 : 1359-1367, 2003

15 Seki N, "Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction" 28 : 197-201, 2009

16 Steers WD, "Alterations in afferent pathways from the urinary bladder of the rat in response to partial urethral obstruction" 310 : 401-410, 1991

17 Tubaro A, "A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia" 166 : 172-176, 2001